Cutler Group’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,600
| Closed | -$41K | – | 2287 |
|
|
2023
Q4 | $41K | Buy |
4,600
+3,743
| +437% | +$30.8K | ﹤0.01% | 1554 |
|
|
2023
Q3 | $6K | Sell |
857
-1,296
| -60% | -$12.7K | ﹤0.01% | 2735 |
|
|
2023
Q2 | $20K | Sell |
2,153
-794
| -27% | -$8.24K | ﹤0.01% | 1836 |
|
|
2023
Q1 | $32K | Sell |
2,947
-1,211
| -29% | -$10.7K | ﹤0.01% | 1625 |
|
|
2022
Q4 | $17K | Buy |
4,158
+900
| +28% | +$5.22K | ﹤0.01% | 2318 |
|
|
2022
Q3 | $24K | Sell |
3,258
-20,582
| -86% | -$178K | ﹤0.01% | 2462 |
|
|
2022
Q2 | $239K | Sell |
23,840
-3,573
| -13% | -$39.9K | 0.02% | 905 |
|
|
2022
Q1 | $339K | Sell |
27,413
-45,779
| -63% | -$708K | 0.02% | 862 |
|
|
2021
Q4 | $1.67M | Buy |
73,192
+25,559
| +54% | +$606K | 0.07% | 298 |
|
|
2021
Q3 | $1.05M | Buy |
47,633
+38,433
| +418% | +$610K | 0.05% | 440 |
|
|
2021
Q2 | $119K | Buy |
9,200
+8,500
| +1,214% | +$108K | 0.01% | 1718 |
|
|
2021
Q1 | $9K | Sell |
700
-4,600
| -87% | -$66.7K | ﹤0.01% | 3865 |
|
|
2020
Q4 | $73K | Buy |
5,300
+2,400
| +83% | +$34.9K | ﹤0.01% | 1732 |
|
|
2020
Q3 | $42K | Buy |
2,900
+400
| +16% | +$5.79K | ﹤0.01% | 1897 |
|
|
2020
Q2 | $40K | Buy |
+2,500
| New | +$40K | ﹤0.01% | 1892 |
|
|
2019
Q4 | – | Sell |
-2,800
| Closed | -$25.8K | – | 3963 |
|
|
2019
Q3 | $14K | Sell |
2,800
-2,700
| -49% | -$16.3K | ﹤0.01% | 2393 |
|
|
2019
Q2 | $36K | Buy |
5,500
+1,400
| +34% | +$8.92K | ﹤0.01% | 1785 |
|
|
2019
Q1 | $26K | Sell |
4,100
-500
| -11% | -$3.32K | ﹤0.01% | 1846 |
|
|
2018
Q4 | $31K | Buy |
+4,600
| New | +$26.5K | ﹤0.01% | 1786 |
|
|
2018
Q2 | – | Sell |
-600
| Closed | -$3.35K | – | 4166 |
|
|
2018
Q1 | $3K | Sell |
600
-1,900
| -76% | -$10.2K | ﹤0.01% | 3516 |
|
|
2017
Q4 | $11K | Sell |
2,500
-2,800
| -53% | -$15.5K | ﹤0.01% | 3024 |
|
|
2017
Q3 | $33K | Sell |
5,300
-48,141
| -90% | -$303K | ﹤0.01% | 2635 |
|
|
2017
Q2 | $327K | Buy |
53,441
+26,001
| +95% | +$175K | 0.01% | 944 |
|
|
2017
Q1 | $201K | Buy |
27,440
+26,440
| +2,644% | +$122K | 0.01% | 1187 |
|
|
2016
Q4 | $2K | Buy |
+1,000
| New | +$3.22K | ﹤0.01% | 5543 |
|
Other funds holding AUPH
AC
NMC
N
TCM